Difficulty: Medium
Average Score: 84%
Practice
This drug is contraindicated in patients with bronchial asthma:
Correct answer
A
Rationale
In this case, the correct answer is A) Propranolol. Propranolol is a non-selective beta-blocker that can cause bronchospasm and worsen bronchial asthma symptoms. Beta-blockers like propranolol can lead to constriction of the airways in individuals with asthma, making it contraindicated in this population.
Option B) Clonidine is an alpha-2 adrenergic agonist commonly used to treat high blood pressure. It does not have the same bronchoconstrictive effects as beta-blockers like propranolol and is not contraindicated in patients with bronchial asthma.
Option C) Enalapril is an angiotensin-converting enzyme (ACE) inhibitor used to manage hypertension and heart failure. Enalapril does not have direct effects on bronchial asthma and is generally safe for use in patients with this condition.
Option D) Nifedipine is a calcium channel blocker that is often prescribed for hypertension and angina. It does not have the same mechanism of action as beta-blockers and does not pose a risk of bronchoconstriction in patients with asthma.
Educationally, understanding drug contraindications is crucial for healthcare providers to ensure safe and effective treatment for their patients. Knowing which medications to avoid in specific patient populations, such as those with bronchial asthma in this case, helps prevent potential adverse reactions and complications. This knowledge enhances clinical decision-making and promotes patient safety and positive health outcomes.
Option B) Clonidine is an alpha-2 adrenergic agonist commonly used to treat high blood pressure. It does not have the same bronchoconstrictive effects as beta-blockers like propranolol and is not contraindicated in patients with bronchial asthma.
Option C) Enalapril is an angiotensin-converting enzyme (ACE) inhibitor used to manage hypertension and heart failure. Enalapril does not have direct effects on bronchial asthma and is generally safe for use in patients with this condition.
Option D) Nifedipine is a calcium channel blocker that is often prescribed for hypertension and angina. It does not have the same mechanism of action as beta-blockers and does not pose a risk of bronchoconstriction in patients with asthma.
Educationally, understanding drug contraindications is crucial for healthcare providers to ensure safe and effective treatment for their patients. Knowing which medications to avoid in specific patient populations, such as those with bronchial asthma in this case, helps prevent potential adverse reactions and complications. This knowledge enhances clinical decision-making and promotes patient safety and positive health outcomes.